Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis
Formyl peptide receptor-1 (FPR1) is a pattern recognition receptor that is mostly expressed by myeloid cells. In patients with colorectal cancer (CRC), a loss-of-function polymorphism (rs867228) in the gene coding for FPR1 has been associated with reduced responses to chemotherapy or chemoradiothera...
Saved in:
| Main Authors: | Julie Le Naour, Léa Montégut, Yuhong Pan, Sarah Adriana Scuderi, Pierre Cordier, Adrien Joseph, Allan Sauvat, Valerio Iebba, Juliette Paillet, Gladys Ferrere, Ludivine Brechard, Claire Mulot, Grégory Dubourg, Laurence Zitvogel, Jonathan G. Pol, Erika Vacchelli, Pierre-Laurent Puig, Guido Kroemer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | OncoImmunology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/2162402X.2023.2237354 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cancer Immunology: From Immunosurveillance to Immunoescape
by: Siti Boedina Kresno
Published: (2008-01-01) -
Molecular hydrogen as a potential mediator of the antitumor effect of inulin consumption
by: Victor Pascal-Moussellard, et al.
Published: (2025-04-01) -
Tumor-infiltrating lymphocytes in Wilms tumor
by: Devendra Kumar Yadav, et al.
Published: (2020-01-01) -
A laminin α4–CD8+ T cell axis shapes the prognostic impact of macrophages and regulatory T cells in early-stage colorectal cancer
by: Elena Nonnast, et al.
Published: (2025-12-01) -
Peto’s paradox: 2 problems 2 answers
by: Chika Edward Uzoigwe
Published: (2025-02-01)